Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
3SBio Inc. (沈阳三生制药) in-licensed the China...
3SBio Inc. (沈阳三生制药) has formed a strategic...
3SBio (沈阳三生制药) and Ascentage Pharma will...
3SBio Inc. in-licensed the China rights to voclosporin, a...
Golden Meditech raised $40 million in private equity for...
3SBio Inc. acquired worldwide rights to a clinical-stage...
China is expected to announce a $1.5 trillion, five-year...
3SBio Inc. was granted SFDA manufacturing approval of an...
3SBio reported the SFDA has approved its high-dose...
Novartis may IPO on the Shanghai stock exchange, which...
Upcoming Events
BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here
Register here
Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events
Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here